Use Clause 92 of the Indian Patent Act, break Remdesivir monopoly, issue Compulsory License
India is one of the largest generic drug manufacturers in the world and there should be no reason why Remdesivir and other COVID-19 drugs cannot be made available rapidly and at affordable prices to India and the world.
Modi Government slept over Chinese encroachment in Ladakh since 2015
As the face-off between India and China continues in the newly formed Union Territory of Ladakh, Modi Government’s inability to deal with China comes...
Strategic Partnership clause delays Indian Navy P-75 I submarine project
Indian Navy P-75 1 submarine project (Project - 75 (l) or P 75 (l)) is a part of Phase I of the 30 Year...